Bestcare Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.70 Cr
- Paid Up Capital ₹ 1.62 Cr
- Company Age 13 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.07 Cr
- Revenue Growth -1.98%
- Profit Growth -63.24%
- Ebitda -31.94%
- Net Worth 2.36%
- Total Assets 3.06%
About Bestcare Formulations
Bestcare Formulations Private Limited (BFPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 July 2011 and has a history of 13 years and six months. Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.70 Cr and a paid-up capital of Rs 1.62 Cr.
The company currently has active open charges totaling ₹7.07 Cr.
Selvaramu Kasi and Deva Manivannan serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232TZ2011PTC017247
-
Company No.
017247
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Jul 2011
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Bestcare Formulations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Selvaramu Kasi
|
Director | 12-Jul-2011 | Current |
|
Deva Manivannan
|
Director | 12-Jul-2011 | Current |
Financial Performance of Bestcare Formulations.
Bestcare Formulations Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.98% decrease. The company also saw a substantial fall in profitability, with a 63.24% decrease in profit. The company's net worth moved up by a moderate rise of 2.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bestcare Formulations?
Unlock access to Bestcare Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Pharmafrench Private LimitedSelvaramu Kasi is a mutual person
Charges (Loans)
₹7.07 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 6.97 Cr
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Apr 2023 | Others | ₹1.00 M | Open |
| 20 Jun 2013 | State Bank Of India | ₹6.97 Cr | Open |
How Many Employees Work at Bestcare Formulations?
Unlock and access historical data on people associated with Bestcare Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bestcare Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bestcare Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.